share_log

万东医疗最新公告:第三季度净利降13.41%至3710.17万元

The latest announcement of Wandong Medical: net profit in the third quarter fell by 13.41% to 37.1017 million yuan.

證券之星 ·  Oct 27, 2021 05:20

Wandong Medical released a report for the third quarter of 2021 that the company realized operating income of 306 million yuan, an increase of 31.13% over the same period last year. Net profit belonging to shareholders of listed companies was 37.1017 million yuan, down 13.41% from the same period last year. Net profit belonging to shareholders of listed companies after deducting non-recurring gains and losses was 36.5496 million yuan, down 7.16% from the same period last year; and basic earnings per share was 0.069 yuan.

According to the 2021 report of Wandong Medical, the company's main income was 495 million yuan, down 1.63% from the same period last year; the net profit was 83.2103 million yuan, down 20.9% from the same period last year; and the non-net profit was 72.8558 million yuan, down 26.6% from the same period last year. Among them, in the second quarter of 2021, the company's main income in a single quarter was 255 million yuan, up 0.75% from the same period last year; and the net profit in a single quarter was 34.2136 million yuan, down 37.22% from the same period last year. The non-net profit in a single quarter was 26.3375 million yuan, down 48.86% from the same period last year; the debt ratio was 13.45%, the investment income was 11.5881 million yuan, the financial expenses were-3.1702 million yuan, and the gross profit margin was 48.34%.

In the last 90 days, a total of three agencies rated the stock, including two buying ratings and one overweight rating; in the past three months, the net outflow of financing was 35.7212 million, resulting in a decrease in the financing balance; and the net outflow of securities was 2.7827 million, and the balance of securities lending decreased. According to the Securities Star valuation analysis tool, Wandong Medical (600055) good company has a rating of 3.5star, a good price rating of 2.5star, and a comprehensive valuation rating of 3 stars.

The chairman of the company is Hu Ziqiang. Mr. Hu Ziqiang: born in 1957, PhD degree, joined Midea in 2012, once worked in GE, Samsung, and served as Deputy General Manager of Wuxi Little Swan Co., Ltd., currently vice president of the company, concurrently serves as Midea CTO, and serves as chairman of the subsidiary listed company Beijing Wandong Medical Co., Ltd.

This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If there are any questions in the article, please contact us.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment